{"transactions":[{"id":735837,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:22.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options will vest on October 16, 2025, and the remaining 75% will vest in equal monthly tranches over the following 36 months."}],"balance_after":166100,"derivative":{"exercise_price":13.6,"expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001104659-26-074574","document":"tm2618034-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926074574/tm2618034-1_4seq1.xml","form_type":"4"}},{"id":735836,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer"}}],"security":"Common Stock","published_at":"2026-06-16T20:05:22.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":13.6,"value":13600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001104659-26-074574","document":"tm2618034-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926074574/tm2618034-1_4seq1.xml","form_type":"4"}},{"id":748681,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:46:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":25907,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026)."}],"balance_after":69967,"source":{"system":"sec-edgar","filing":"0001649903-26-000002","document":"wk-form4_1780692359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000164990326000002/wk-form4_1780692359.xml","form_type":"4"}},{"id":914045,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-09T21:06:36.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":44123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in equal monthly installments over 48 months commencing from February 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":44123,"derivative":{"exercise_price":76.43,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":44123},"source":{"system":"sec-edgar","filing":"0001104659-26-012064","document":"tm265512-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926012064/tm265512-2_4seq1.xml","form_type":"4"}},{"id":1085907,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-17T20:41:57.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":19506,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than\n50 weeks from the date hereof)."}],"balance_after":44060,"source":{"system":"sec-edgar","filing":"0001005286-25-000090","document":"wk-form4_1752784888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528625000090/wk-form4_1752784888.xml","form_type":"4"}},{"id":1276086,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-02-10T22:21:33.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":123559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in equal monthly tranches over 48 months"}],"balance_after":123559,"derivative":{"exercise_price":14.76,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":123559},"source":{"system":"sec-edgar","filing":"0001583648-25-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000158364825000017/edgardoc.xml","form_type":"4/A","original_submission_date":"2025-02-07"}},{"id":1276085,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-02-10T22:21:33.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":5373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in equal monthly tranches over 48 months"}],"balance_after":5373,"derivative":{"exercise_price":14.76,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":5373},"source":{"system":"sec-edgar","filing":"0001583648-25-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000158364825000017/edgardoc.xml","form_type":"4/A","original_submission_date":"2025-02-07"}},{"id":1328100,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-18T01:43:01.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":167100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options will vest on October 16, 2025, and the remaining 75% will vest in equal monthly tranches over the following 36 months."}],"balance_after":167100,"derivative":{"exercise_price":13.6,"expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":167100},"source":{"system":"sec-edgar","filing":"0001062993-24-020818","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000106299324020818/form4.xml","form_type":"4"}},{"id":1400573,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"exercise","planned":false,"acquired":false,"shares":9377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Option was previously reported as a Grant of 30,189 shares on May 5, 2022, at an exercise price of $90.68 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer and shall be fully vested on February 5, 2026."}],"balance_after":42436,"derivative":{"exercise_price":52.84,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":9377},"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400572,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"exercise","planned":false,"acquired":false,"shares":395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":49.99,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":395},"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400571,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":false,"shares":4982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":395,"derivative":{"exercise_price":49.99,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":4982},"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400570,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"sale","planned":false,"acquired":false,"shares":201,"price":102.0541,"value":20512.8741,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $102.0450 to $102.0950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50777,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400569,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"sale","planned":false,"acquired":false,"shares":7090,"price":101.605,"value":720379.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $101.0450 to $102.0400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50978,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400568,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"sale","planned":false,"acquired":false,"shares":2481,"price":100.0517,"value":248228.2677,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $100.0000 to $100.2750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":58068,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400567,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"exercise","planned":false,"acquired":true,"shares":9377,"price":52.84,"value":495480.68,"ownership":{"direct":true},"balance_after":60549,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400566,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-23","kind":"exercise","planned":false,"acquired":true,"shares":395,"price":49.99,"value":19746.05,"ownership":{"direct":true},"balance_after":51172,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400565,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-20","kind":"sale","planned":false,"acquired":false,"shares":6275,"price":104.1017,"value":653238.1675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.4300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50777,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1400564,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-24T23:41:15.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":true,"shares":4982,"price":49.99,"value":249050.18,"ownership":{"direct":true},"balance_after":57052,"source":{"system":"sec-edgar","filing":"0002001011-24-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000087/edgardoc.xml","form_type":"4"}},{"id":1404117,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":3340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This Option was previously reported as a Grant of 25,000 shares on August 06, 2015, which vested in full on August 06, 2019, at an exercise price of $104.59 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was previously reported as a Grant of 25,000 shares on August 06, 2015, which vested in full on August 06, 2019, at an exercise price of $104.59 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":18500,"derivative":{"exercise_price":60.94,"expiration_date":"2025-08-06","underlying":"Common Stock","underlying_shares":3340},"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404116,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This Option was previously reported as a Grant of 15,225 shares on February 24, 2017, which vested in full on February 24, 2021, at an exercise price of $100.38 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Option was previously reported as a Grant of 15,225 shares on February 24, 2017, which vested in full on February 24, 2021, at an exercise price of $100.38 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":12452,"derivative":{"exercise_price":58.49,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":849},"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404115,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This Option was previously reported as a Grant of 30,750 shares on February 13, 2020, at an exercise price of $95.68 per share , but was adjusted pursuant to the OmniAb Inc. separation from the issuer, then vested in full on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Option was previously reported as a Grant of 30,750 shares on February 13, 2020, at an exercise price of $95.68 per share , but was adjusted pursuant to the OmniAb Inc. separation from the issuer, then vested in full on February 13, 2024."}],"balance_after":25949,"derivative":{"exercise_price":55.75,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404114,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":5377,"derivative":{"exercise_price":49.99,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":671},"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404113,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1938,"price":105,"value":203490.0,"ownership":{"direct":true},"balance_after":52070,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404112,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":3340,"price":60.94,"value":203539.6,"ownership":{"direct":true},"balance_after":54008,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404111,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":319,"price":105,"value":33495.0,"ownership":{"direct":true},"balance_after":50668,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404110,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":671,"price":49.99,"value":33543.29,"ownership":{"direct":true},"balance_after":50987,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404109,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":472,"price":105,"value":49560.0,"ownership":{"direct":true},"balance_after":50316,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404108,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":849,"price":58.49,"value":49658.01,"ownership":{"direct":true},"balance_after":50788,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404107,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":485,"price":105,"value":50925.0,"ownership":{"direct":true},"balance_after":49939,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1404106,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-09-18T23:55:29.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":914,"price":55.75,"value":50955.5,"ownership":{"direct":true},"balance_after":50424,"source":{"system":"sec-edgar","filing":"0002001011-24-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000082/edgardoc.xml","form_type":"4"}},{"id":1423669,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-08-27T00:15:37.000Z","date":"2024-08-26","kind":"sale","planned":false,"acquired":false,"shares":5212,"price":106.3214,"value":554147.1368,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.8100 to $106.6900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49510,"source":{"system":"sec-edgar","filing":"0002001011-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000078/edgardoc.xml","form_type":"4"}},{"id":1423668,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-08-27T00:15:37.000Z","date":"2024-08-26","kind":"sale","planned":false,"acquired":false,"shares":6177,"price":105.016,"value":648683.832,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.7200 to $105.6700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54722,"source":{"system":"sec-edgar","filing":"0002001011-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000078/edgardoc.xml","form_type":"4"}},{"id":1423667,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-08-27T00:15:37.000Z","date":"2024-08-23","kind":"sale","planned":false,"acquired":false,"shares":4275,"price":105.1319,"value":449438.8725,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.0000 to $105.4450. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60899,"source":{"system":"sec-edgar","filing":"0002001011-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000078/edgardoc.xml","form_type":"4"}},{"id":1423666,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-08-27T00:15:37.000Z","date":"2024-08-23","kind":"sale","planned":false,"acquired":false,"shares":2037,"price":104.0945,"value":212040.4965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":65174,"source":{"system":"sec-edgar","filing":"0002001011-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000078/edgardoc.xml","form_type":"4"}},{"id":1423665,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-08-27T00:15:37.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":1157,"price":105.54,"value":122109.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.2500 to $105.6500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":67211,"source":{"system":"sec-edgar","filing":"0002001011-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000078/edgardoc.xml","form_type":"4"}},{"id":1426850,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-21T23:52:33.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":24554,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024)."}],"balance_after":24554,"source":{"system":"sec-edgar","filing":"0001628280-24-038088","document":"wk-form4_1724284348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024038088/wk-form4_1724284348.xml","form_type":"4"}},{"id":1435339,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2024-08-13T21:21:14.000Z","date":"2024-08-09","kind":"sale","planned":false,"acquired":false,"shares":18245,"price":98.5,"value":1797132.5,"ownership":{"direct":true},"balance_after":68368,"source":{"system":"sec-edgar","filing":"0002001011-24-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000071/edgardoc.xml","form_type":"4"}},{"id":1464308,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief Operating"}}],"security":"Common Stock","published_at":"2024-07-02T23:45:27.000Z","date":"2024-06-28","kind":"other","planned":false,"acquired":true,"shares":350,"price":60.707,"value":21247.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":86613,"source":{"system":"sec-edgar","filing":"0002001011-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000064/edgardoc.xml","form_type":"4"}},{"id":1516553,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief Operating"}}],"security":"Common Stock","published_at":"2024-05-15T23:34:53.000Z","date":"2024-05-14","kind":"sale","planned":false,"acquired":false,"shares":520,"price":85.6841,"value":44555.732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.6250 to $85.7650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86263,"source":{"system":"sec-edgar","filing":"0002001011-24-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000052/edgardoc.xml","form_type":"4"}},{"id":1516552,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief Operating"}}],"security":"Common Stock","published_at":"2024-05-15T23:34:53.000Z","date":"2024-05-14","kind":"sale","planned":false,"acquired":false,"shares":13638,"price":85.0826,"value":1160356.4988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5950 to $85.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86783,"source":{"system":"sec-edgar","filing":"0002001011-24-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000052/edgardoc.xml","form_type":"4"}},{"id":1516551,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief Operating"}}],"security":"Common Stock","published_at":"2024-05-15T23:34:53.000Z","date":"2024-05-13","kind":"sale","planned":false,"acquired":false,"shares":3440,"price":84.5431,"value":290828.264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5000 to $84.8750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100421,"source":{"system":"sec-edgar","filing":"0002001011-24-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000052/edgardoc.xml","form_type":"4"}},{"id":1611040,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CHIEF OPERATING"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-29T23:50:43.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":58544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter."}],"balance_after":58544,"derivative":{"exercise_price":89.2,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":58544},"source":{"system":"sec-edgar","filing":"0002001011-24-000029","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000029/edgardoc.xml","form_type":"4"}},{"id":1611039,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CHIEF OPERATING"}}],"security":"Common Stock","published_at":"2024-02-29T23:50:43.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":14416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":103861,"source":{"system":"sec-edgar","filing":"0002001011-24-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000029/edgardoc.xml","form_type":"4"}},{"id":1639465,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CHIEF OPERATING"}}],"security":"Common Stock","published_at":"2024-02-17T01:10:27.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4778,"price":74.65,"value":356677.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units."}],"balance_after":89445,"source":{"system":"sec-edgar","filing":"0002001011-24-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000018/edgardoc.xml","form_type":"4"}},{"id":1689342,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CHIEF OPERATING"}}],"security":"Common Stock","published_at":"2024-01-04T21:07:14.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2917,"price":72.31,"value":210928.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units."}],"balance_after":94223,"source":{"system":"sec-edgar","filing":"0002001011-24-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000009/edgardoc.xml","form_type":"4"}},{"id":1720596,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CHIEF OPERATING"}}],"security":"Common Stock","published_at":"2023-12-06T20:27:13.000Z","date":"2023-12-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1984,"price":59.61,"value":118266.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units."}],"balance_after":97140,"source":{"system":"sec-edgar","filing":"0002001011-23-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101123000003/edgardoc.xml","form_type":"4"}},{"id":1832451,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CHIEF OPERATING"}}],"security":"Common Stock","published_at":"2023-07-10T22:42:48.000Z","date":"2023-06-30","kind":"other","planned":false,"acquired":true,"shares":376,"price":56.78,"value":21349.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c)."}],"balance_after":99124,"source":{"system":"sec-edgar","filing":"0000886163-23-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000045/edgardoc.xml","form_type":"4"}},{"id":1991379,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-28T01:52:13.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":24628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from February 23, 2023, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after February 23, 2023 and the remaining stock options vesting in 42 equal monthly installments thereafter."}],"balance_after":24628,"derivative":{"exercise_price":75.09,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":24628},"source":{"system":"sec-edgar","filing":"0000899243-23-006297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323006297/doc4.xml","form_type":"4"}},{"id":1991378,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-28T01:52:13.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":9069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on February 15, 2024; February 15, 2025; and February 15, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":98748,"source":{"system":"sec-edgar","filing":"0000899243-23-006297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323006297/doc4.xml","form_type":"4"}},{"id":2009247,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-18T00:23:56.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":2890,"price":72.98,"value":210912.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units."}],"balance_after":89679,"source":{"system":"sec-edgar","filing":"0000899243-23-005552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323005552/doc4.xml","form_type":"4"}},{"id":2074595,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-12-30T22:00:36.000Z","date":"2022-12-28","kind":"tax_withholding","acquired":false,"shares":3859,"price":66.29,"value":255813.11,"ownership":{"direct":true},"balance_after":92569,"source":{"system":"sec-edgar","filing":"0000899243-22-039583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322039583/doc4.xml","form_type":"4"}},{"id":2076336,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-27T23:34:49.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":25967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from the date of grant, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after the date of grant and the remaining stock options vesting in 42 equal monthly installments thereafter."}],"balance_after":25967,"derivative":{"exercise_price":67.03,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":25967},"source":{"system":"sec-edgar","filing":"0000899243-22-039412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322039412/doc4.xml","form_type":"4"}},{"id":2085669,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-15T23:17:27.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter."}],"balance_after":30000,"derivative":{"exercise_price":63.62,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-038699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322038699/doc4.xml","form_type":"4"}},{"id":2085668,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-12-15T23:17:27.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on December 5, 2023; December 5, 2024; and December 5, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":96428,"source":{"system":"sec-edgar","filing":"0000899243-22-038699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322038699/doc4.xml","form_type":"4"}},{"id":2100548,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-12-02T02:42:52.000Z","date":"2022-11-30","kind":"tax_withholding","acquired":false,"shares":3593,"price":72.9,"value":261929.7,"ownership":{"direct":true},"balance_after":82428,"source":{"system":"sec-edgar","filing":"0000899243-22-037330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322037330/doc4.xml","form_type":"4"}},{"id":2126412,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-11-04T01:10:22.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":27714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 19,258 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes securities that were adjusted pursuant to an anti-dilution provision in connection with the separation of the OmniAb, Inc. from the Issuer on November 1, 2022."}],"balance_after":86021,"source":{"system":"sec-edgar","filing":"0000899243-22-035047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322035047/doc4.xml","form_type":"4"}},{"id":2194426,"issuer":{"id":7776,"kind":"organization","name":"FF EAI Robotics Ecosystem Inc."},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-04T20:16:02.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the stock option vest over three years in equal annual installments from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.5136,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-021319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315222021319/ownership.xml","form_type":"4"}},{"id":2213136,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-07-07T00:00:29.000Z","date":"2022-06-30","kind":"other","acquired":true,"shares":164,"price":75.837,"value":12437.268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c)."}],"balance_after":52532,"source":{"system":"sec-edgar","filing":"0000886163-22-000107","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000107/edgardoc.xml","form_type":"4"}},{"id":2233317,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-06-14T21:54:43.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":8062,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52368,"source":{"system":"sec-edgar","filing":"0000886163-22-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000090/edgardoc.xml","form_type":"4"}},{"id":2278420,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-10T00:10:30.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":30189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of options to purchase shares of common stock (\"Option Shares\"), exerciseable over a 3-year, 9-month period measured from the date of grant, 12-1/2% after three months, then 1/48th of the Option Shares per month thereafter.  The date of grant is 05/05/2022."}],"balance_after":30189,"derivative":{"exercise_price":90.68,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":30189},"source":{"system":"sec-edgar","filing":"0000886163-22-000056","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000056/edgardoc.xml","form_type":"4"}},{"id":2392844,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-02-17T01:23:22.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":1532,"price":123.68,"value":189477.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/03/2021."}],"balance_after":44306,"source":{"system":"sec-edgar","filing":"0000886163-22-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000021/edgardoc.xml","form_type":"4"}},{"id":2392843,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-02-17T01:23:22.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":969,"price":123.68,"value":119845.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/13/2020."}],"balance_after":45838,"source":{"system":"sec-edgar","filing":"0000886163-22-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000021/edgardoc.xml","form_type":"4"}},{"id":2392842,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-02-17T01:23:22.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":906,"price":123.68,"value":112054.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2019."}],"balance_after":46807,"source":{"system":"sec-edgar","filing":"0000886163-22-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000021/edgardoc.xml","form_type":"4"}},{"id":2423184,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-01-29T01:43:17.000Z","date":"2022-01-26","kind":"tax_withholding","acquired":false,"shares":2309,"price":113.68,"value":262487.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":47713,"source":{"system":"sec-edgar","filing":"0000886163-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000014/edgardoc.xml","form_type":"4"}},{"id":2423183,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-01-29T01:43:17.000Z","date":"2022-01-26","kind":"tax_withholding","acquired":false,"shares":1319,"price":113.68,"value":149943.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":50022,"source":{"system":"sec-edgar","filing":"0000886163-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000014/edgardoc.xml","form_type":"4"}},{"id":2423182,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-01-29T01:43:17.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":6848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 03/09/2020 and were eligible to vest based on the Issuer achievement of certain performance objectives during the two-year performance period ending December 31, 2021.  On January 26, 2022, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":51341,"source":{"system":"sec-edgar","filing":"0000886163-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000014/edgardoc.xml","form_type":"4"}},{"id":2423181,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2022-01-29T01:43:17.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":4803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 05/29/2019 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2021.  On January 26, 2022, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":44493,"source":{"system":"sec-edgar","filing":"0000886163-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000014/edgardoc.xml","form_type":"4"}},{"id":2646162,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-07-02T21:13:39.000Z","date":"2021-06-30","kind":"other","acquired":true,"shares":247,"price":85.9095,"value":21219.6465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c)."}],"balance_after":39690,"source":{"system":"sec-edgar","filing":"0000886163-21-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000097/edgardoc.xml","form_type":"4"}},{"id":2852086,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-02-18T23:27:08.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":969,"price":172.46,"value":167113.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/13/2020."}],"balance_after":39443,"source":{"system":"sec-edgar","filing":"0000886163-21-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000040/edgardoc.xml","form_type":"4"}},{"id":2852085,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-02-18T23:27:08.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":906,"price":172.46,"value":156248.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2019."}],"balance_after":40412,"source":{"system":"sec-edgar","filing":"0000886163-21-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000040/edgardoc.xml","form_type":"4"}},{"id":2852084,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-02-18T23:27:08.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":434,"price":172.46,"value":74847.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 03/02/2018."}],"balance_after":41318,"source":{"system":"sec-edgar","filing":"0000886163-21-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000040/edgardoc.xml","form_type":"4"}},{"id":2877996,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-05T22:02:02.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":11591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of options to purchase shares of common stock (\"Option Shares\"), exerciseable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter.  The date of grant is 02/03/2021."}],"balance_after":11591,"derivative":{"exercise_price":177.5,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":11591},"source":{"system":"sec-edgar","filing":"0000886163-21-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000027/edgardoc.xml","form_type":"4"}},{"id":2877995,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-02-05T22:02:02.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":10819,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41752,"source":{"system":"sec-edgar","filing":"0000886163-21-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000027/edgardoc.xml","form_type":"4"}},{"id":2894013,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-01-28T00:03:01.000Z","date":"2021-01-25","kind":"tax_withholding","acquired":false,"shares":1440,"price":156.01,"value":224654.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":30933,"source":{"system":"sec-edgar","filing":"0000886163-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000014/edgardoc.xml","form_type":"4"}},{"id":2894012,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-01-28T00:03:01.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":4803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 05/29/2019 and were eligible to vest based on the Issuer achievement of certain performance objectives during the two-year performance period ending December 31, 2020.  On January 25, 2021, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":32373,"source":{"system":"sec-edgar","filing":"0000886163-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000014/edgardoc.xml","form_type":"4"}},{"id":2894011,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-01-28T00:03:01.000Z","date":"2021-01-25","kind":"tax_withholding","acquired":false,"shares":671,"price":156.01,"value":104682.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":27570,"source":{"system":"sec-edgar","filing":"0000886163-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000014/edgardoc.xml","form_type":"4"}},{"id":2894010,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2021-01-28T00:03:01.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":2305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 05/30/2018 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2020.  On January 25, 2021, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":28241,"source":{"system":"sec-edgar","filing":"0000886163-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000014/edgardoc.xml","form_type":"4"}},{"id":3095774,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2020-07-02T00:05:38.000Z","date":"2020-06-30","kind":"other","acquired":true,"shares":238,"price":89.029,"value":21188.902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c)."}],"balance_after":25936,"source":{"system":"sec-edgar","filing":"0000886163-20-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000083/edgardoc.xml","form_type":"4"}},{"id":3118619,"issuer":{"id":7776,"kind":"organization","name":"FF EAI Robotics Ecosystem Inc."},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T01:22:18.000Z","date":"2020-06-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the stock option vest over three years in equal annual installments from the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":5.13,"expiration_date":"2030-06-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-010817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315220010817/ownership.xml","form_type":"4"}},{"id":3170598,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2020-04-24T23:24:11.000Z","date":"2019-02-15","kind":"tax_withholding","acquired":false,"shares":435,"price":120.86,"value":52574.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 03/02/2018."}],"balance_after":15303,"source":{"system":"sec-edgar","filing":"0000886163-20-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000052/edgardoc.xml","form_type":"4"}},{"id":3170597,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2020-04-24T23:24:11.000Z","date":"2019-02-15","kind":"tax_withholding","acquired":false,"shares":377,"price":120.86,"value":45564.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/24/2017."}],"balance_after":15738,"source":{"system":"sec-edgar","filing":"0000886163-20-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000052/edgardoc.xml","form_type":"4"}},{"id":3170596,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2020-04-24T23:24:11.000Z","date":"2019-02-15","kind":"tax_withholding","acquired":false,"shares":354,"price":120.86,"value":42784.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2016."}],"balance_after":16115,"source":{"system":"sec-edgar","filing":"0000886163-20-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000052/edgardoc.xml","form_type":"4"}},{"id":3268092,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-18T22:05:47.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":30750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of options to purchase shares of common stock (\"Option Shares\"), exerciseable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter.  The date of grant is 02/13/2020."}],"balance_after":30750,"derivative":{"exercise_price":95.68,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":30750},"source":{"system":"sec-edgar","filing":"0000886163-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000014/edgardoc.xml","form_type":"4"}},{"id":3268091,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2020-02-18T22:05:47.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":6848,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26864,"source":{"system":"sec-edgar","filing":"0000886163-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000014/edgardoc.xml","form_type":"4"}},{"id":3331844,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-12-26T19:01:49.000Z","date":"2019-12-20","kind":"tax_withholding","acquired":false,"shares":979,"price":105.87,"value":103646.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":20016,"source":{"system":"sec-edgar","filing":"0000886163-19-000209","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/edgardoc.xml","form_type":"4"}},{"id":3331843,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-12-26T19:01:49.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":2305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 05/30/2018 and were eligible to vest based on the Issuer achievement of certain performance objectives during the two-year performance period ending December 31, 2019.  On December 20, 2019, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":20995,"source":{"system":"sec-edgar","filing":"0000886163-19-000209","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/edgardoc.xml","form_type":"4"}},{"id":3331842,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-12-26T19:01:49.000Z","date":"2019-12-20","kind":"tax_withholding","acquired":false,"shares":1135,"price":105.87,"value":120162.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":18690,"source":{"system":"sec-edgar","filing":"0000886163-19-000209","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/edgardoc.xml","form_type":"4"}},{"id":3331841,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-12-26T19:01:49.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":2674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 03/29/2017 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2019.  On December 20, 2019, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":19825,"source":{"system":"sec-edgar","filing":"0000886163-19-000209","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/edgardoc.xml","form_type":"4"}},{"id":3408417,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"0.75% Convertible Senior Notes due 2023","published_at":"2019-09-23T14:14:42.000Z","date":"2019-09-19","kind":"purchase","acquired":true,"price":989937.5,"reported_value":1175000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The notes are convertible at any time prior to the close of business on November 14, 2022 (1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of the Issuer?s common stock on such trading day is greater than 130% of the conversion price on such trading day; (2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or (3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes."}],"derivative":{"exercise_price":248.48,"expiration_date":"2023-05-15","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000886163-19-000175","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000175/edgardoc.xml","form_type":"4"}},{"id":3425367,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-09-03T23:34:12.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":500,"price":86.1815,"value":43090.75,"ownership":{"direct":true},"balance_after":17151,"source":{"system":"sec-edgar","filing":"0000886163-19-000161","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000161/edgardoc.xml","form_type":"4"}},{"id":3472853,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-07-03T01:49:37.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":182,"price":97.0275,"value":17659.005,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c)."}],"balance_after":16651,"source":{"system":"sec-edgar","filing":"0000886163-19-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000120/edgardoc.xml","form_type":"4"}},{"id":3661497,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-13T21:35:47.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":29298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of options to purchase shares of common stock (\"Option Shares\"), exerciseable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter.  The date of grant is 02/11/19."}],"balance_after":29298,"derivative":{"exercise_price":117.97,"expiration_date":"2029-03-02","underlying":"Common Stock","underlying_shares":29298},"source":{"system":"sec-edgar","filing":"0000886163-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000037/edgardoc.xml","form_type":"4"}},{"id":3661496,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-02-13T21:35:47.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":6404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16469,"source":{"system":"sec-edgar","filing":"0000886163-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000037/edgardoc.xml","form_type":"4"}},{"id":3687374,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-01-25T21:30:49.000Z","date":"2019-01-23","kind":"tax_withholding","acquired":false,"shares":612,"price":111.78,"value":68409.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":10065,"source":{"system":"sec-edgar","filing":"0000886163-19-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/edgardoc.xml","form_type":"4"}},{"id":3687373,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-01-25T21:30:49.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":2230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 03/29/2017 and were eligible to vest based on the Issuer achievement of certain performance objectives during the two-year performance period ending December 31, 2018.  On January 23, 2019, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":10677,"source":{"system":"sec-edgar","filing":"0000886163-19-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/edgardoc.xml","form_type":"4"}},{"id":3687372,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-01-25T21:30:49.000Z","date":"2019-01-23","kind":"tax_withholding","acquired":false,"shares":713,"price":111.78,"value":79699.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs."}],"balance_after":8447,"source":{"system":"sec-edgar","filing":"0000886163-19-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/edgardoc.xml","form_type":"4"}},{"id":3687371,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2019-01-25T21:30:49.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":2418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs).  Each PSU represented a contingent right to receive one share of the Issuer common stock.  The PSUs were originally granted on 02/11/2016 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2018.  On January 23, 2019, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares."}],"balance_after":9160,"source":{"system":"sec-edgar","filing":"0000886163-19-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/edgardoc.xml","form_type":"4"}},{"id":3830954,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-30T00:35:16.000Z","date":"2018-08-29","kind":"exercise","acquired":false,"shares":11540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to reporting person of options to purchase shares of common stock (\"Option Shares\"), exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter.  The date of grant is 02/11/16."}],"balance_after":6924,"derivative":{"exercise_price":85.79,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":11540},"source":{"system":"sec-edgar","filing":"0000886163-18-000125","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000125/edgardoc.xml","form_type":"4"}},{"id":3830953,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2018-08-30T00:35:16.000Z","date":"2018-08-29","kind":"sale","acquired":false,"shares":18357,"price":256.6901,"value":4712060.1657,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.218 to $257.170, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":6742,"source":{"system":"sec-edgar","filing":"0000886163-18-000125","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000125/edgardoc.xml","form_type":"4"}},{"id":3830952,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":37594,"kind":"person","name":"Korenberg Matthew E","position":1,"cik":"0001649903","reported_name":"Korenberg Matthew E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Finance & Strategy and CFO"}}],"security":"Common Stock","published_at":"2018-08-30T00:35:16.000Z","date":"2018-08-29","kind":"exercise","acquired":true,"shares":11540,"price":85.79,"value":990016.6,"ownership":{"direct":true},"balance_after":25099,"source":{"system":"sec-edgar","filing":"0000886163-18-000125","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000125/edgardoc.xml","form_type":"4"}}],"next_cursor":"2018-08-30T00:35:16.000000Z,3830952"}